The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of nivolumab monotherapy versus nivolumab combined with ipilimumab in advanced gastrointestinal stromal tumor (GIST).
 
Arun S. Singh
Stock and Other Ownership Interests - AntiCancer; Certis Oncology Solutions
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Lilly
Speakers' Bureau - Eisai; Lilly; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Nanocarrier (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; Eisai; Lilly; Novartis
Other Relationship - Certis Oncology Solutions
 
Bartosz Chmielowski
Consulting or Advisory Role - Array BioPharma; Biothera; Bristol-Myers Squibb; Compugen; Genentech/Roche; HUYA Bioscience International; Iovance Biotherapeutics; Janssen; Merck; Novartis; Regeneron
Speakers' Bureau - Genentech/Roche; Janssen Oncology
Research Funding - Advenchen Laboratories (Inst); Aeglea Biotherapeutics (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Biothera (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); Idera (Inst); Immunocore (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst); Lilly/ImClone (Inst); Macrogenics (Inst); Merck (Inst); Neon Therapeutics (Inst); Rgenix (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Biothera; Bristol-Myers Squibb; Compugen; Genentech/Roche; HUYA Bioscience International; Iovance Biotherapeutics; Janssen; Regeneron
 
J. Randolph Hecht
No Relationships to Disclose
 
Lee S. Rosen
Research Funding - Bayer (Inst); Lilly (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Regeneron (Inst)
 
Warren Allen Chow
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst)
 
Xiaoyan Wang
No Relationships to Disclose
 
Sandra Brackert
No Relationships to Disclose
 
Carlos Adame
Employment - Syneos Health
 
John Bovill
No Relationships to Disclose
 
Elena Schink
No Relationships to Disclose
 
Michael Douek
No Relationships to Disclose
 
Jomjit Chantharasamee
No Relationships to Disclose
 
Karlton Wong
No Relationships to Disclose
 
Frederick C. Eilber
Stock and Other Ownership Interests - AntiCancer-PDOX; Certis Oncology Solutions
 
John A. Glaspy
No Relationships to Disclose